欢迎访问ProbeChem中文网站,英文网站请访问www.probechem.com

首页-小分子抑制剂&激动剂-PI3K/Akt/mTOR Pathway-Akt-MK 2206 dihydrochloride
MK 2206 dihydrochloride

Chemical Structure : MK 2206 dihydrochloride

CAS No.: 1032350-13-2

MK 2206 dihydrochloride (MK-2206 dihydrochloride;MK2206 dihydrochloride)

货号: PC-42551Not For Human Use, Lab Use Only.

MK 2206 dihydrochloride is a potent, orally active allosteric Akt inhibitor with IC50 of 5/12 nM for Akt1/Akt2 respectively.

规格 价格 库存 数量
10 mg ¥880 In stock
25 mg ¥1480 In stock
50 mg ¥2480 In stock
100 mg Get quote

大包装,大折扣!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

纯度 & COA & 质检文件 纯度: >98% (HPLC) Select Batch:

生物&药学活性

MK 2206 dihydrochloride is a potent, orally active allosteric Akt inhibitor with IC50 of 5/12 nM for Akt1/Akt2 respectively.
MK 2206 shows 5-fold less potent against human Akt3 (IC50=65 nM).
MK 2206 synergistically inhibits cell proliferation of human cancer cell lines in combination with erlotinib or lapatinib in vitro.
MK 2206 suppresses the Akt phosphorylation that is induced by carboplatin and gemcitabine.

物理化学性质&存储条件

分子量 480.389
分子式 C25H23Cl2N5O
外观性状 Solid
CAS No.
储存条件
固体粉末
-20 °C 12 个月; 4°C 6 个月
配置液
-80 °C 6 个月; -20°C 6 个月
Shipping
Solubility

DMSO

Chemical Name/SMILES

1,2,4-Triazolo[3,4-f][1,6]naphthyridin-3(2H)-one, 8-[4-(1-aminocyclobutyl)phenyl]-9-phenyl-, hydrochloride (1:2)

参考文献

1. Hirai H, et al. Mol Cancer Ther. 2010 Jul;9(7):1956-67.

2. Cheng Y, et al. Mol Cancer Ther. 2012 Jan;11(1):154-64.

3. Whicker ME, et al. BMC Cancer. 2016 Jul 27;16:550.

备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

联系我们 sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

询单

  • *产品名称:
  • *姓名:
  • *邮箱:
  • *公司名称:
  • *询单数量:
  • *国籍:
  • 询单信息: